Abstract:COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug repurposing has been employed to rapidly find a cure; but despite great efforts, no drug or vaccine is presently available for treating or prevention of COVID-19. Apart from antivirals, immunotherapeutic strategies are suggested considering the role of the immune response as the host defense against the virus, and the fact that SARS-CoV-2 suppresses interferon induction as an immune evasion strategy. Active immunization through vaccines, interferon administration, passive immunotherapy by convalescent plasma or synthesized monoclonal and polyclonal antibodies, as well as immunomodulatory drugs, are different immunotherapeutic approaches that will be mentioned in this review. The focus would be on passive immunotherapeutic interventions.Interferons might be helpful in some stages. Vaccine development has been followed with unprecedented speed. Some of these vaccines have been advanced to human clinical trials. Convalescent plasma therapy is already practiced in many countries to help save the lives of severely ill patients. Different antibodies that target various steps of SARS-CoV-2 pathogenesis or the associated immune responses are also proposed.For treating the cytokine storm induced at a late stage of the disease in some patients, immune modulation through JAK inhibitors, corticosteroids, and some other cognate classes are evaluated.Given the changing pattern of cytokine induction and immune responses throughout the COVID-19 disease course, different adapted approaches are needed to help patients. Gaining more knowledge about the detailed pathogenesis of SARS-CoV-2, its interplay with the immune system, and viral-mediated responses are crucial to identify efficient preventive and therapeutic approaches. A systemic approach seems essential in this regard.

Current status of potential therapeutic candidates for the COVID-19 crisis

Potential therapeutic options for COVID-19: an update on current evidence

Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.

Therapeutic strategies for COVID-19: progress and lessons learned

An Update on Current Therapeutic Drugs Treating COVID-19

Insights into Biological Therapeutic Strategies for COVID-19

Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives

Current strategies against COVID-19

Current and future therapeutical approaches for COVID-19

COVID-19 Antiviral and Treatment Candidates: Current Status

Current treatment strategies for COVID‐19 (Review)

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

Current state-of-the-art and potential future therapeutic drugs against COVID-19

Update: Drug Treatment Options for Coronavirus Disease 2019 (COVID-19).

Recent progress of antiviral therapy for coronavirus disease 2019

COVID-19 drug discovery and treatment options

Medication Therapy Strategies for the Coronavirus Disease 2019 (COVID-19): Recent Progress and Challenges

Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities

Immunotherapeutic approaches to curtail COVID-19

Therapeutic Options for COVID-19: A Review